Metabolic programming therapy for resolving pathogenic inflammation in multiple sclerosis
A novel enzyme-based therapeutic approach that reprograms immune cells from a pathogenic inflammatory state to homeostasis in multiple sclerosis (MS). Using indoleamine 2,3-dioxygenase 1 (IDO) delivered systemically as P...